60
56
13
11
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7428 |
SBI-115
|
GPCR19 | GPCR/G Protein |
SBI-115 是TGR5 (GPCR19)拮抗剂,对 TGR5 降低多囊性肝病的肝囊肿形成具有抑制作用。 | |||
TQ0252 |
BAR502
|
FXR; GPCR19; Autophagy | Autophagy; GPCR/G Protein; Metabolism |
BAR502 是一种 GPBAR1 和 FXR 双重激动剂,IC50分别为0.4 μM 和 2 μM。 | |||
T4083 |
BAR501
BAR 501 |
GPCR19 | GPCR/G Protein |
BAR501是高效选择性的 GPBAR1激动剂(EC50:1 μM)。 | |||
T8599 |
Betazole dihydrochloride
盐酸倍他唑,Betazole hydrochloride |
Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Betazole dihydrochloride (Betazole hydrochloride) 是吡唑类组胺,是一种口服活性 H2受体激动剂,能诱导胃酸分泌,导致胆总管压力立即显著升高。它作为一种诊断剂,用于研究胃酸分泌能力。 | |||
T4352 |
SB756050
SB-756050,SB 756050 |
GPCR19 | GPCR/G Protein |
SB756050 是TGR5选择性激动剂。它用于二型糖尿病研究的潜力。 | |||
T11515 |
Gut restricted-7
GR-7 |
Potassium Channel | Membrane transporter/Ion channel |
Gut restricted-7 (GR-7) 是一种具有口服活性的共价泛胆盐水解酶 (BSH) 抑制剂,对肠道有组织选择性。它可减少小鼠粪便中肠道细菌的BSH 活性并降低去结合型胆汁酸水平。 | |||
T0843 |
Triamterene
氨苯蝶啶,Ademine,SKF8542 |
Sodium Channel; GPCR19 | GPCR/G Protein; Membrane transporter/Ion channel |
Ademine 是一种压敏型上皮钠离子通道(ENaC)阻断剂,具有利尿的作用。 | |||
T1824 |
TGR5 Receptor Agonist
|
GPCR19 | GPCR/G Protein |
TGR5 Receptor Agonist 是一种TGR5(GPCR19)激动剂。 | |||
T8818 |
TC-G 1005
(4-环丙基-3,4-二氢-1(2H)-喹喔啉基)[4-(2,5-二甲基苯氧基)-3-吡啶基]甲酮 |
GPCR19 | GPCR/G Protein |
TC-G 1005 是具有口服活性的TGR5选择性激动剂,能够激活 hTGR5 (EC50:0.72 nM)和 mTGR5 (EC50:6.2 nM)。它能够减少小鼠体内葡萄糖水平。 | |||
T32873 |
Maralixibat Chloride
SHP-625,SHP625,Livmarli,LUM001 chloride,Lopixibat chloride,Lopixibat,SHP625 chloride,SHP 625 |
Potassium Channel | Membrane transporter/Ion channel |
Maralixibat Chloride (LUM001 chloride) 是一种钠依赖性的胆汁酸转运抑制剂,可阻止胆汁酸在肠肝内的再循环 | |||
T13622 |
Cholestyramine
Colestyramine,考来烯胺,Cholestyramine resin |
Others | Others |
Cholestyramine (Cholestyramine resin) 是一种胆汁酸结合树脂,能够抑制肠胆汁酸吸收导致增加粪便胆汁酸排泄,提高胆固醇胆汁酸合成。 | |||
T35371 |
Colesevelam Hydrochloride
|
Others | Others |
Colesevelam Hydrochloride 是一种胆汁酸隔离剂,在体外对甘胆酸均具有更高的亲和力。 Colesevelam Hydrochloride 抑制胆汁酸重吸收,导致胆汁酸合成增加并降低胆汁淤积性瘙痒症和克罗恩病患者的胆固醇水平。 | |||
T36522 |
Isoallolithocholic acid
Alloisolithocholic Acid,AILCA,3β-Hydroxy-5α-cholanic acid |
Others | Others |
Isoallolithocholic acid (3β-Hydroxy-5α-cholanic acid) 是一种 T 细胞调节剂,是一种胆汁酸代谢物,具有抗炎活性,与人类免疫稳态有关。 | |||
T64334 |
Glycolithocholic acid, sodium salt
|
Others | Others |
Glycolithocholic acid, sodium salt 是 Glycolithocholic acid 的钠盐。Glycolithocholic acid 是一种甘氨酸结合的次级胆汁酸。Glycolithocholic acid 可用于诊断溃疡性结肠炎 (UC),非酒精性脂肪性肝炎 (NASH0) 和原发性硬化性胆管炎 (PSC)。 | |||
T16376 |
Odevixibat
A4250 |
Others | Others |
Odevixibat (A4250) (A4250) 是一种有效的选择性回肠胆汁酸转运蛋白 (IBAT) 抑制剂。Odevixibat (A4250) 可减轻小鼠模型中的胆汁淤积性肝和胆管损伤。Odevixibat (A4250)可用于原发性胆汁性肝硬化的研究。 | |||
T9154 |
Sodium taurodeoxycholate hydrate
牛磺去氧胆酸钠,Taurodeoxycholic acid sodium salt monohydrate |
Others | Others |
Sodium taurodeoxycholate hydrate (Taurodeoxycholic acid sodium salt monohydrate) 已用于一项研究,以评估亚胶束浓度的胆汁盐对脂质双层膜的影响。 | |||
T15209 |
Elobixibat
AZD 7806,A 3309 |
Others | Others |
Elobixibat (A 3309) 是回肠胆汁酸转运蛋白的抑制剂(小鼠、人和犬 IBAT 的 IC50:0.13 nM、0.53 nM 和 5.8 nM)。 Elobixibat 可用于慢性特发性便秘的研究。 | |||
TP1198 |
Sincalide ammonium
SQ19844 ammonium,CCK-8 ammonium,Cholecystokinin octapeptide ammonium |
cholecystokinin | GPCR/G Protein |
Sincalide ammonium (CCK-8 ammonium) 是一种有效的氨基酸多肽激素胆囊收缩素 (CCK) 的类似物,是保留了 CCK 的大部分生物活性的活性片段。Sincalide ammonium 促进胆汁的分泌,使胆囊收缩并使 Oddi 的括约肌松弛,从而促进胆汁排入十二指肠。Sincalide ammonium 可通过注射促进胆囊收缩,常用于辅助诊断胆囊、胰腺疾病和胆囊造影术。 | |||
T7294 |
Aramchol
C20-FABAC |
Others | Others |
Aramchol (C20-FABAC) 是一种胆酸和花生酸的结合物,能够降低硬脂酰辅酶 A 去饱和酶 1 (SCD1) 的活性。它具有用于非酒精性脂肪性肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH) 的潜能。 | |||
T11426 |
Gly-β-MCA
|
FXR | Metabolism |
Gly-β-MCA 是一种具有口服生物活性、肠道选择性和有效的法尼酯X受体 (FXR) 抑制剂,是一种胆汁酸,可用于研究肥胖和糖尿病。 | |||
T65070 |
Chenodeoxycholic Acid sodium salt
CDCA sodium salt |
FXR | Metabolism |
Chenodeoxycholic Acid sodium salt (CDCA sodium salt) 是一种人体中的胆汁酸,能够活化核受体 FXR,可挽救痉挛性截瘫 5 型和脑黄瘤病患者诱导多能干细胞衍生神经元的轴突变性,可用于研究胰腺坏死。 | |||
T8752 |
BAR 501 impurity
|
GPCR19 | GPCR/G Protein |
BAR 501 impurity 在 BAR501 制剂中发现的一种杂质,可作为 G 蛋白偶联胆汁酸激活受体 (GP-BAR1) 的激动剂。 BAR501 杂质 (10 µM) 在 GP-BAR1 报告基因检测中诱导荧光素酶活性增加 150%。 | |||
T37771 |
Taurolithocholic Acid 3-sulfate (sodium salt)
|
Others | Others |
Taurolithocholic acid 3-sulfate (TLCA3S) is a metabolite of the conjugated bile acid taurolithocholic acid . TLCA3S has been used to study bile acid transport in cellular models and to induce pancreatitis in mouse models of bile acid infusion pancreatitis. | |||
T32420 |
Kryptogenin
Cryptogenine,Cryptogenin |
Others | Others |
Kryptogenin, derived from carp bile, can be used to synthesize C27-intermediates in bile acid biosynthesis. | |||
T37845 |
Taurocholic Acid 3-sulfate (sodium salt)
|
Others | Others |
Taurocholic acid 3-sulfate (TCA3S) is a metabolite of the conjugated bile acid taurocholic acid .1Plasma levels of TCA3S are elevated in wild-type andSortilin 1(Sort1) knockout mice at 6 hours following bile duct ligation (BDL) and are further elevated inSort1knockout mice at 24 hours post-BDL.2 1.Lefebvre, P., Cariou, B., Lien, F., et al.Role of bile acids and bile acid receptors in metabolic regulationPhysiol. Rev.89(1)147-191(2009) 2.Li, J., Woolbright, B.L., Zhao, W., et al.Sortilin 1 loss-o... | |||
T30270 |
Azidobenzamidotaurocholate
|
Others | Others |
Azido Benzamido Taurocholate is a bile acid transporter. | |||
T85011 |
7,12-Diketolithocholic Acid
7,12-Dioxolithocholic Acid |
Others | Others |
7,12-Diketolithocholic acid, a bile acid, exhibits elevated plasma levels in patients experiencing cholestasis. | |||
T70688 |
S 0960
|
Others | Others |
S 0960 is a dimeric bile acid analogue that acts as a specific inhibitor of the apical sodium-dependent bile salt transporter (ASBT) in the ileum. | |||
T32797 |
Lithocholenic acid
|
Others | Others |
Lithocholenic acid is a bile acid that acts as a detergent to solubilize fats for absorption. | |||
T27015 |
Cicrotoic acid
|
Others | Others |
Cicrotoic acid, a biochemical drug, acts on bile flow and liquid composition of human bile. | |||
T16818 | S-8921 | Others | Others |
S-8921 is an inhibitor of ileal Na+/bile acid cotransporter. | |||
T2968L |
Hyodeoxycholic acid sodium salt
Sodium hyodeoxycholate,HDCA sodium |
Others | Others |
Hyodeoxycholic acid sodium salt is a natural secondary bile acid. It improves high-density lipoprotein function, reduces farnesoid X receptor antagonist bile acids, and induces strong cytotoxicity, apoptosis, and IL-8 synthesis. | |||
T69558 |
Barixibat
|
Others | Others |
Barixibat is a bile acid transport inhibitor. | |||
T37178 |
Norhyodeoxycholic Acid
|
Others | Others |
Norhyodeoxycholic acid (NHDCA) is a synthetic bile acid and a derivative of hyodeoxycholic acid .1,2 NHDCA is an intermediate in the synthesis of 3β-sulfooxy-7β-hydroxy-24-nor-5-cholen-23-oic acid, which has been used as an internal standard for the quantification of δ5-bile acid conjugates that have been identified in patients with Niemann-Pick disease type C1.3 |1. Schteingart, C.D., and Hofmann, A.F. Synthesis of 24-nor-5β-cholan-23-oic acid derivatives: A convenient and efficient one-carbon ... | |||
T28700 |
SC-435 mesylate
SC-435,SC435,SC 435 |
Others | Others |
SC-435 is an ileal apical sodium co-dependent bile acid transporter (ASBT). SC-435 inhibits plasma cholesterol. | |||
T10090 |
264W94
|
Others | Others |
264W94 is a robust inhibitor of the ileal bile acid transporter (IBAT) and a novel agent for reducing cholesterol levels. It exhibits CYP7A1 induction and demonstrates significant antilipemic activity. | |||
T17236 |
Volixibat
SHP626,LUM002 |
Others | Others |
Volixibat is a highly selective and competitive apical sodium-dependent bile acid transporter inhibitor. Volixibat has the potential for treatment for non-alcoholic steatohepatitis. | |||
T83900 |
12β-Hydroxyisocholic Acid
LCA,Lagocholic Acid |
Others | Others |
12β-Hydroxyisocholic acid是一种胆酸,同时也是胆酸的异构体。在酒精性肝损伤的小鼠模型中,12β-Hydroxyisocholic acid的肝脏水平会升高。 | |||
T69622 |
Ritivixibat
|
Others | Others |
Ritivixibat为回肠胆汁酸转运蛋白(IBAT)抑制剂,同时也是胆汁酸调节剂,主要适用于心血管疾病、脂肪酸代谢及葡萄糖利用障碍、胃肠道和肝脏疾病的研究。 | |||
T36075 |
Cholic Acid anilide
|
Others | Others |
Cholic acid anilide is a synthetic bile acid and derivative of cholic acid that inhibits the germination of C. difficile strain R20291 spores in vitro (IC50 = 1.8 μM).1 |1. Sharma, S.K., Yip, C., Esposito, E.X., et al. The design, synthesis, and characterizations of spore germination inhibitors effective against an epidemic strain of Clostridium difficile. J. Med. Chem. 61(15), 6759-6778 (2018). | |||
T75599 |
Glycodehydrocholic acid
|
Others | Others |
Glycodehydrocholic acid,一种胆汁酸与甘氨酸的结合物,主要用于诊断癌症及其他疾病。 | |||
T37416 |
Tauro-α-muricholic Acid (sodium salt)
|
Others | Others |
Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary bile acid α-muricholic acid . TαMCA is common in rodents but has also been found in small amounts in human serum. | |||
T37846 |
Taurohyocholic Acid (sodium salt)
|
Others | Others |
Taurohyocholic acid (THCA) is a taurine-conjugated form of the porcine-specific primary bile acid hyocholic acid .1THCA inhibits precipitation of cholesterol crystals by stabilizing cholesterol in the liquid-crystalline phase.2It prevents cholestasis and cellular necrosis induced by taurolithocholic acid in isolated rat livers.3THCA levels are increased in the urine of patients with hepatitis B-induced cirrhosis.4 | |||
T37798 |
Petromyzonol
|
Others | Others |
Petromyzonol is a tetrahydroxy stearol which serves as the primary spawning pheromone in adult sea lamprey. It is produced in the bile of sea lamprey larvae from the bile acid precursor allocholic acid. While the adult sea lamprey is relatively insensitive to petromyzonol itself, the C-24 sulfate ester (petromyzonol sulfate) is a pheromone and a spawning chemoattractant which can be detected at very low concentrations by lamprey olfactory chemoreceptors. Petromyzonol, petromyzonol sulfate, and a... | |||
T85281 |
Taurohyocholic Acid sodium
Taurohyocholate,THCA,Tauro-γ-muricholic Acid,Taurine Hyocholate |
Others | Others |
Taurohyocholic acid (THCA), a taurine-conjugated form of porcine-specific primary bile acid hyocholic acid, inhibits cholesterol crystal precipitation by stabilizing cholesterol in the liquid-crystalline phase and prevents cholestasis and cellular necrosis in isolated rat livers induced by taurolithocholic acid. Additionally, THCA levels rise in the urine of patients with hepatitis B-induced cirrhosis. | |||
T84944 |
3-Epideoxycholic Acid
EDCA |
Others | Others |
3-Epideoxycholic acid (EDCA), a secondary bile acid and an epimer of deoxycholic acid, serves as a steroidal host compound in the enantioselective purification of (2R,3S)-3-methyl-2-pentanol from its racemates via enclathration. Additionally, decreased fecal levels of EDCA have been observed in pediatric patients with non-alcoholic fatty liver disease (NAFLD). | |||
T63793 |
Tauro-ω-muricholic acid sodium
|
Others | Others |
Tauro-ω-muricholic acid sodium (TωMCA sodium) 是一种tauro-α-muricholic acid 的类似物,是来源于肝脏的胆汁酸。Tauro-ω-muricholic acid sodium 能用作早发性新生儿败血症 (EOS) 和胆汁淤积的血清标志物。 | |||
T36132 |
3β-OH-7-Oxocholenic Acid
|
Others | Others |
3β-OH-7-Oxocholenic acid is a bile acid.1 It is also a metabolite of 7β-hydroxy cholesterol in rats. Conjugated forms of 3β-OH-7-oxocholenic acid have been found in the urine of patients with Neimann-Pick disease type C.2,3 |1. Norii, T., Yamaga, N., and Yamasaki, K. Metabolism of 7β-hydroxycholesterol-4-14C in rat. Steroids 15(3), 303-326 (1970).|2. Alvelius, G., Hjalmarson, O., Griffiths, W.J., et al. Identification of unusual 7-oxygenated bile acid sulfates in a patient with Niemann-Pick dise... | |||
T37854 |
Cholic Acid 7-sulfate
|
Others | Others |
Cholic acid 7-sulfate is a metabolite of the primary bile acid cholic acid.[1],[2] It is produced by conjugation of a sulfate group with the hydroxy group at position 7 of cholic acid in the liver and gut. Fecal levels of cholic acid 7-sulfate are increased in male, but not female, mice fed a diet supplemented with cholic acid or chenodeoxycholic acid.[2] | |||
T37251 |
Celecoxib Carboxylic Acid Acyl-β-D-Glucuronide
|
Others | Others |
Celecoxib carboxylic acid acyl-β-D-glucuronide is a phase II metabolite of celecoxib . Celecoxib is an anti-inflammatory compound from the diaryl heterocycle class that selectively inhibits cyclooxygenase-2 (COX-2; IC50s = 22.9 and 0.05 μM for COX-1 and COX-2, respectively). Celecoxib carboxylic acid acyl-β-D-glucuronide is a minor metabolite, accounting for 2% of the administered dose in human urine and rat bile. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2965 |
Deoxycholic acid
Cholorebic,去氧胆酸,脱氧胆酸,Deoxycholate,Desoxycholic acid,Cholanoic Acid,Cholerebic |
Endogenous Metabolite; GPCR19 | GPCR/G Protein; Metabolism |
Deoxycholic acid (Cholanoic Acid) 是 G 蛋白偶联胆汁酸受体 TGR5的激活剂。 | |||
T5077 |
Deoxycholic acid sodium salt
脱氧胆酸钠,Sodium deoxycholate,Sodium Desoxycholate |
Endogenous Metabolite; GPCR19 | GPCR/G Protein; Metabolism |
Deoxycholic acid sodium salt (Sodium deoxycholate) 是 G 蛋白偶联胆汁酸受体TGR5的激活剂。 | |||
T8153 |
glycohyodeoxycholic acid
|
Others; Endogenous Metabolite | Metabolism; Others |
Glycohyodeoxycholic acid 是一种人体次级胆汁酸猪去氧胆酸的主要代谢物,能够预防胆结石的形成。 | |||
T19189 |
Allocholic acid
|
Others | Others |
Allocholic acid 是一种胆汁酸,在脊椎动物中发现,在肝脏再生和致癌过程中会重新出现,也是成熟嗅觉系统的特定性刺激物。 | |||
T0022 |
Taurine
牛磺酸,2-Aminoethanesulfonic acid |
LDL; Endogenous Metabolite; Autophagy | Autophagy; Metabolism |
Taurine (2-Aminoethanesulfonic acid) 是一种含硫氨基酸的有机渗透剂,为胆汁盐的形成提供底物,并在调节细胞内游离钙浓度方面发挥作用,有激活脂肪细胞自噬的能力。 | |||
T0700 |
Ursodeoxycholic acid
熊去氧胆酸,UDCA,Ursodiol |
Potassium Channel; Endogenous Metabolite | Membrane transporter/Ion channel; Metabolism |
Ursodeoxycholic acid (UDCA)是一种有效的肝脏特异性脂肪酸转运蛋白 5 (FATP5) 抑制剂,通过 FATP5 依赖性方式抑制原代肝细胞摄取长链脂肪酸。Ursodeoxycholic acid 能够抑制胆固醇的吸收,用于溶解胆结石,并具有研究与肥胖相关的脂肪肝疾病的潜力。 | |||
T31964 |
Glycolithocholic acid
Lithocholic acid glycine conjugate,甘氨石胆酸,Lithocholylglycine |
Endogenous Metabolite | Metabolism |
Glycolithocholic acid (Lithocholic acid glycine conjugate) 属于内源性代谢产物,是甘氨酸结合的次级胆汁酸。它可用于诊断非酒精性脂肪性肝炎,溃疡性结肠炎和原发性硬化性胆管炎。 | |||
T2968 |
Hyodeoxycholic acid
NSC 60672,猪去氧胆酸,α-Hyodeoxycholic Acid,HDCA |
FXR; Endogenous Metabolite; GPCR19 | GPCR/G Protein; Metabolism |
Hyodeoxycholic acid (NSC 60672) 是由肠道菌群在小肠中形成的次级胆汁酸,是TGR5(GPCR19)的激动剂, CHO 细胞中的EC50=31.6 µM。它已用于研究高胆固醇血症的治疗。 | |||
T13502 |
3-Oxo-5β-cholanoic acid
3-氧代-5β-胆烷酸,Dehydrolithocholic acid |
ROR | Metabolism |
3-Oxo-5β-cholanoic acid (Dehydrolithocholic acid) 是胆汁酸的一种代谢产物。3-Oxo-5β-cholanoic acid 直接与关键转录因子RORγt(Kd=1.13 μM) 结合抑制TH17细胞分化。 | |||
T13522 |
7-Ketolithocholic acid
3α-Hydroxy-7-oxo-5β-cholanic acid |
Endogenous Metabolite | Metabolism |
7-Ketolithocholic acid (3α-Hydroxy-7-oxo-5β-cholanic acid) (3α-Hydroxy-7-oxo-5β-cholanic acid) is capable of absorption and serves to suppress the production of endogenous bile acid and the secretion of biliary cholesterol. | |||
T29078 |
Ursodeoxycholic acid sodium
UDCA Na,UDCA sodium,Sodium Ursodeoxycholate,熊去氧胆酸钠盐,Ursodiol sodium,Ursodeoxycholic Acid (sodium salt),Ursodeoxycholate sodium |
FXR; Endogenous Metabolite; GPCR19 | GPCR/G Protein; Metabolism |
Ursodeoxycholic acid sodium (Sodium Ursodeoxycholate) 是一种天然存在的次级胆汁酸,具有抗炎和细胞保护活性。Ursodeoxycholic acid sodium 作为信号分子,通过与胆汁酸激活受体相互作用发挥其作用,包括 G 蛋白偶联胆汁酸受体 5 (TGR5) 和法尼醇 X 受体 (FXR)。 | |||
TN2215 |
Taurochenodeoxycholic acid sodium
牛磺鹅去氧胆酸钠盐,Sodium taurochenodeoxycholate,牛磺鹅去氧胆酸钠 |
Apoptosis; Endogenous Metabolite | Apoptosis; Metabolism |
Taurochenodeoxycholic acid sodium (Sodium taurochenodeoxycholate) 是动物胆汁酸的主要生物活性物质之一。它可诱导细胞凋亡,具有抗炎和免疫调节作用。 | |||
T2A2481 |
Taurochenodeoxycholic Acid
Chenodeoxycholyltaurine,TCDCA,Chenyltaurine,Taurochenodeoxycholate,12-Deoxycholyltaurine,牛磺鹅去氧胆酸 |
Apoptosis; TNF; Caspase; Endogenous Metabolite | Apoptosis; Metabolism; Proteases/Proteasome |
Taurochenodeoxycholic Acid (12-Deoxycholyltaurine) 是动物胆汁酸的主要生物活性物质之一,可诱导细胞凋亡,具有明显的抗炎和免疫调节作用。 | |||
T5234 |
Glycoursodeoxycholic acid
Ursodeoxycholylglycine,甘氨熊胆酸,GUDCA |
Others; Endogenous Metabolite | Metabolism; Others |
Glycoursodeoxycholic acid (Ursodeoxycholylglycine) 是一种酰基甘氨酸和胆汁酸-甘氨酸缀合物,是熊去氧胆酸的代谢物。 | |||
T13505 |
3α,12β-Dihydroxycholanoic acid
Lagodeoxycholic acid |
Endogenous Metabolite | Metabolism |
3α,12β-Dihydroxycholanoic acid (Lagodeoxycholic acid) 是一种广泛存在于动物体内的胆汁酸。 | |||
T19124 |
3-Oxocholic acid
3-Ketocholic acid |
Endogenous Metabolite | Metabolism |
3-Oxocholic acid(3-Ketocholic acid) 是胆汁酸的代谢产物,也是产气荚膜梭菌在肠道中由胆汁降解的主要产物。33-Oxocholic acid 是一种主要存在于哺乳动物的胆汁中类固醇酸。 | |||
T2744 |
Methyl Cholate
胆酸甲酯,Cholic acid methyl ester |
Others | Others |
Methyl Cholate 是胆酸的甲酯形式。其中胆酸是一种由肝脏产生的主要胆汁酸,由胆固醇合成。Methyl Cholate 具有抗炎抗肿瘤活性。 | |||
T0516 |
Dehydrocholate sodium
去氢胆酸钠,Sodium dehydrocholate |
Endogenous Metabolite; Lipid | Metabolism |
Dehydrocholate sodium 是胆液排泄增多剂,能够提高胆汁输出,清除提高的胆汁酸负载。 | |||
T7331 |
Ursocholic acid
|
Endogenous Metabolite | Metabolism |
Ursocholic acid 是存在于哺乳动物胆汁中的胆酸,通过小鼠肠道菌群转化为脱氧胆酸。脱氧胆酸是7α-羟化类固醇脱氢酶和肝细胞核因子1α的抑制剂。 | |||
T5072 |
Glycocholic acid hydrate
|
Others; Endogenous Metabolite | Metabolism; Others |
Glycocholic acid hydrate 是内源性代谢产物的一种。 | |||
T10196 |
7α-Hydroxy-4-cholesten-3-one
7-hydroxy-4-cholesten-3-one |
Others | Others |
7α-Hydroxy-4-cholesten-3-one 是一种可穿过血脑屏障的胆汁酸前体,可作为肝胆汁酸合成的指标。7α-Hydroxy-4-cholesten-3-one 是一种孕烷 X 受体 (PXR) 激动剂。7α-Hydroxy-4-cholesten-3-one 可用于研究与胆汁酸生物合成缺陷有关的疾病。 | |||
TJA2398 |
Taurodeoxycholic acid sodium hydrate
Sodium taurodeoxycholate monohydrate,Taurodeoxychloic Acid sodium hydrate,Taurohyodeoxycholic acid sodium salt,牛磺猪去氧胆酸 |
Apoptosis; Caspase | Apoptosis; Proteases/Proteasome |
Taurodeoxycholic acid sodium hydrate (Sodium taurodeoxycholate monohydrate) 通过阻断钙介导的凋亡通路和 Caspase-12的活化来阻止细胞凋亡。它可用于原发性胆汁性肝硬化、胰岛素抵抗、淀粉样变性、囊性纤维化、胆汁淤积和肌萎缩侧索硬化症。 | |||
T7628 |
3b-Hydroxy-5-cholenoic acid
|
Endogenous Metabolite | Metabolism |
3b-Hydroxy-5-cholenoic acid 是内源性的单羟基胆酸的一种,大量崔乃在于患有肝胆管状发育不全的儿童体内。 | |||
T4727 |
Taurolithocholic acid sodium salt
牛磺石胆酸钠,Sodium taurolithocholate |
Others; Calcium Channel | Membrane transporter/Ion channel; Metabolism; Others |
Taurolithocholic acid sodium salt (Sodium taurolithocholate) 是抑胆剂和 Ca2+激动剂,可抑制放射性配体与毒蕈碱 M1 结合。 | |||
T2963 |
Cholic Acid
Cholanic acid,胆汁酸,Cholate,Colalin |
Endogenous Metabolite | Metabolism |
Cholic Acid (Cholate) 是肝脏产生的主要胆汁酸,与牛磺酸或甘氨酸缀合,有助于脂肪吸收和胆固醇排泄。 | |||
T8207 |
Evolitrine
|
Others | Others |
Evolitrine 是一种来源于Acronychia pedunculata、具有抗炎作用的物质。 | |||
T14002 |
12-Ketodeoxycholic acid
|
Endogenous Metabolite | Metabolism |
12-Ketodeoxycholic acid 是一种胆汁酸,由肾脏代谢产生。它是肾脏损伤的标志物。 | |||
T0408 |
Dehydrocholic acid
Dehystolin,Felacrinos,去氢胆酸,Sanocholen,Decholin |
Others | Others |
Dehydrocholic acid (Dehystolin) 是一种由胆酸氧化生成的胆汁酸,用作胆液排泄增多剂,能够增加胆汁产量,清除增加的胆汁酸负荷。 | |||
T35792 |
Isolithocholic Acid
3-Epilithocholic acid,3β-Hydroxy-5β-cholanic acid,β-Lithocholic acid,isoLCA |
Endogenous Metabolite | Metabolism |
Isolithocholic Acid (3-Epilithocholic acid) (β-Lithocholic acid) 是石胆酸的一种同分异构体。Isolithocholic Acid 是一种胆酸,由 Lithocholic acid 或 Lithocholic acid 3α-sulfate 经微生物代谢形成。 | |||
T2831 |
Glycocholic acid
Glycocholate,甘氨胆酸,cholylglycine |
Others; Endogenous Metabolite | Metabolism; Others |
Glycocholic acid (Glycocholate) 是一种胆汁酸,具有抗肿瘤活性,能够靶向作用于耐药泵和非耐药泵通路。 | |||
T37177 |
Norcholic Acid
|
Others | Others |
Norcholic acid is a bile acid and 23-carbon derivative of cholic acid .1Levels of norcholic acid are increased in the urine of patients with liver cirrhosis or cerebrotendinous xanthomatosis (CTX), an inborn error of metabolism characterized by a deficiency in the mitochondrial enzyme sterol 27-hydrolylase (CYP27A1) that leads to progressive neurological symptoms.2,3,4 | |||
T4588 |
Glycochenodeoxycholic Acid
甘氨鹅脱氧胆酸,Glycine chenodeoxycholate,Chenodeoxycholylglycine,GCDCA,Glycochenodeoxycholate,Lithocholylglycine |
Apoptosis; Endogenous Metabolite | Apoptosis; Metabolism |
Glycochenodeoxycholic Acid (Lithocholylglycine) 是一种从脱氧鹅胆酸和甘氨酸在肝脏中形成的胆汁盐,可诱导肝细胞凋亡。它有洗涤剂的作用,可溶解脂肪吸收,并本身被吸收。 | |||
T8294 |
Quercetagitrin
万寿菊苷,槲皮万寿菊素-7-O-Β-吡喃葡萄糖苷,Quercetagetin-7-O-glucoside |
Others | Others |
Quercetagitrin 是分离自非洲万寿菊花 (Tagetes erecta) 中,具有抗炎作用。 | |||
T4070 |
Glycocholic Acid Sodium Salt
Glycocholate Sodium,Sodium Glycocholate,甘氨胆酸钠盐 |
Others | Others |
Glycocholic Acid Sodium Salt (Sodium Glycocholate) 是一种结合胆汁盐和离子生物去污剂。它参与脂肪的乳化。 | |||
T5259 |
Glycochenodeoxycholic acid sodium salt
GCDCA,甘氨鹅脱氧胆酸钠,Sodium glycochenodeoxycholate |
Apoptosis; Others; Endogenous Metabolite | Apoptosis; Metabolism; Others |
Glycochenodeoxycholic acid sodium salt 是一种从脱氧鹅胆酸和甘氨酸在肝脏中形成的胆汁盐,可诱导肝细胞凋亡。它起到洗涤剂的作用,可溶解脂肪吸收,并本身被吸收。 | |||
TWA2417 |
Sodium taurocholate
牛黄胆酸钠(牛胆酸钠,牛胆酸钠盐,牛磺膽酸鈉,牛磺胆酸钠,牛磺胆酸钠盐,牛胆酸钠水合物,水合牛磺胆酸钠,牛胆酸钠(混合物),牛黄胆酸钠(水合),牛磺胆酸钠(标准品)),Taurocholate Sodium |
Others | Others |
Sodium taurocholate (Taurocholate Sodium) hydrate 具有显著的生物学效应,例如通过上调 VEGF-A 的表达抑制肝动脉结扎所致的胆道损伤。对免疫系统具有一定的调节作用。 | |||
TN2259 |
Taurocholic acid
N-Choloyltaurine |
TNF; PI3K | Apoptosis; PI3K/Akt/mTOR signaling |
Taurocholic acid (N-Choloyltaurine) 是一种胆汁酸,参与脂肪的乳化。Taurocholic acid 具有细胞保护作用,可通过 PI3K 介导的途径防止肿瘤坏死因子-α 诱导的胆管细胞损伤。 | |||
T2532 |
Tauroursodeoxycholate
Taurolite,牛磺熊去氧胆酸,Tauroursodeoxycholic Acid,UR 906,Ursodeoxycholyltaurine,TUDCA |
Apoptosis; ERK; P450; Caspase; Endogenous Metabolite | Apoptosis; MAPK; Metabolism; Proteases/Proteasome |
Tauroursodeoxycholate (UR 906) 是一种天然的高度亲水性的三级胆汁酸。Tauroursodeoxycholate 可用于原发性胆汁性肝硬化 (PBC)、胰岛素抵抗、淀粉样变性、囊性纤维化、胆汁淤滞和肌萎缩性侧索硬化症的研究。 | |||
T13506 |
3β-Ursodeoxycholic acid
Isoursodeoxycholic acid |
||
3β-Ursodeoxycholic acid (Isoursodeoxycholic acid) 是一种胆汁酸。3β-Ursodeoxycholic acid 经口服给药表现出良好的耐受性和良好的肠道吸收能力。3β-Ursodeoxycholic acid 可以在肠道和肝脏经历酶异构化,并生成UDCA。 | |||
T1138 |
Taurocholic acid sodium salt hydrate
牛胆酸钠,牛磺胆酸钠水合物,Sodium taurocholate hydrate,Taurocholic Acid sodium hydrate |
Others; Potassium Channel; Endogenous Metabolite | Membrane transporter/Ion channel; Metabolism; Others |
Taurocholic acid sodium salt hydrate (Sodium taurocholate hydrate) 是一种胆汁酸钠盐水合物,作用是参与脂肪的乳化。 | |||
T2202 |
Lithocholic acid
3α-Hydroxy-5β-cholanic acid,石胆酸 |
Apoptosis; Others; FXR; Endogenous Metabolite; Autophagy | Apoptosis; Autophagy; Metabolism; Others |
Lithocholic acid (3α-Hydroxy-5β-cholanic acid) 是由鹅去氧胆酸盐通过细菌作用形成的胆汁酸,通常与甘氨酸或牛磺酸结合,被用作利胆剂。 它作为清洁剂溶解脂肪以供吸收,并且本身被吸收。 | |||
T75319 |
Taurodeoxycholic acid
Taurodeoxychloic acid |
Apoptosis; Calcium Channel; Caspase | Apoptosis; Membrane transporter/Ion channel; Metabolism; Proteases/Proteasome |
Taurodeoxycholic acid (Taurodeoxychloic acid) 是脱氧胆酸的胆汁酸牛磺酸共轭物,是一种人体代谢物,可稳定线粒体膜,减少自由基形成。Taurodeoxycholic acid 通过阻断钙介导的凋亡通路以及 Caspase-12 激活来抑制凋亡 (apoptosis)。Taurodeoxycholic acid具有神经保护活性,可用于研究 3-硝基丙酸诱导或稳定遗传的亨廷顿舞蹈病 (HD) 。 | |||
T0847 |
Chenodeoxycholic acid
CDCA,鹅去氧胆酸,Chenodiol |
Potassium Channel; FXR; Endogenous Metabolite; Autophagy | Autophagy; Membrane transporter/Ion channel; Metabolism |
Chenodeoxycholic acid (CDCA) 是一种胆汁酸,通常与甘氨酸或牛磺酸结合。它作为清洁剂溶解脂肪以供肠道吸收,并被小肠重新吸收。它被用作利胆剂、利胆泻药,以及预防或溶解胆结石。 | |||
T5254 |
Glycodeoxycholate Sodium
Sodium glycyldeoxycholate,Sodium glycodeoxycholate,Glycodeoxycholic acid sodium salt,脱氧甘胆酸钠 |
Others; Endogenous Metabolite | Metabolism; Others |
Glycodeoxycholate Sodium 诱导肝细胞凋亡的机制与内切酶的DNA裂解有关。它是一种次级胆汁酸,由结肠环境中微生物菌群中存在的酶的作用产生。 | |||
T15245 |
Erythromycin estolate
Phtalic anhydride,ilosone |
Antibacterial | Microbiology/Virology |
Erythromycin estolate 是红霉素的衍生物,属于大环内酯类抗生素,常用于研究多种细菌感染。酯酸红霉素对胆汁酸转运有抑制作用,可引起肝损伤,主要是胆汁淤积性肝炎。 | |||
TN6909 |
Polyporusterone B
猪苓酮B,(1R,2R,4S,5R,7R,11R,14S,15R)-14-[(2R,3R)-2,3-dihydroxy-6-methyl-5-methylideneheptan-2-yl]-4,5,11-trihydroxy-2,15-dimethyltetracyclo[8.7.0.02,?.011,1?]heptadec-9-en-8-one |
Others | Others |
Polyporusterone B ((1R,2R,4S,5R,7R,11R,14S,15R)-14-[(2R,3R)-2,3-dihydroxy-6-methyl-5-methylideneheptan-2-yl]-4,5,11-trihydroxy-2,15-dimethyltetracyclo[8.7.0.02,?.011,1?]heptadec-9-en-8-one) 是一种三萜羧酸,从Polyporus umbellatusFries 中分离得到。它对自由基诱导的红细胞裂解 (溶血) 具有抑制作用。 | |||
T36585 |
Isodeoxycholic Acid
isoDCA |
Chloride channel; Antibacterial | Membrane transporter/Ion channel; Microbiology/Virology |
Isodeoxycholic Acid 是一种胆汁酸,由肠道细菌通过脱氧胆酸的表聚作用形成。Isodeoxycholic acid 的临界胶束浓度高于二氯苯甲醚,这表明它的去污活性降低了,而且在抑制七种肠道共生细菌生长方面的活性低于二氯苯甲醚。Isodeoxycholic Acid(0.1%)能抑制几种艰难梭菌菌株在牛磺胆酸诱导下的孢子萌发,并能降低艰难梭菌培养上清对 Vero 细胞的细胞毒性。在高脂饮食诱发肥胖的大鼠模型中,血浆中的Isodeoxycholic acid 水平比正常饮食的大鼠低。 | |||
T19623 |
α-Muricholic acid
|
AChR | Neuroscience |
α-Muricholic acid is the most abundant primary bile acid in rodents. | |||
T40790 |
ω-Muricholic Acid
|
Others | Others |
ω-Muricholic acid (ω-MCA) is a murine-specific secondary bile acid. | |||
T81030 |
Tauro-β-muricholic acid
TβMCA |
FXR | Metabolism |
Tauro-β-muricholic acid (TβMCA) 为一种具有三羟基结构的胆汁酸,是FXR的竞争性、可逆拮抗剂,IC50值为40 μM。此外,Tauro-β-muricholic acid 能够通过维持线粒体膜电位来阻抑胆汁酸引起的肝细胞凋亡,发挥抗凋亡功能。 | |||
------------------------ 更多 ------------------------ |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03342 |
GBA2 Protein, Rat, Recombinant (His)
Bile acid glucosyl transferase GBA2,Glucos... |
Rat | E. coli |
GBA2 Protein, Rat, Recombinant (His) is expressed in E. coli expression system with C-6xHis tag. The predicted molecular weight is 42.6 kDa and the accession number is Q5M868. | |||
TMPJ-00529 |
FABP6 Protein, Human, Recombinant (His)
Ileal Lipid-Binding Protein,I-BABP,Intestinal Bile ... |
Human | E. coli |
Fatty Acid-Binding Protein 6 (FABP6) is cytoplasmic protein that binds long-chain fatty acids and other hydrophobic ligands which belongs to the calycin superfamily. FABP6 expression is restricted in the small intestine to the ileum where it is involved in the enterohepatic circulation of bile acids. FABP6 forms a beta-barrel structure that accommodates the hydrophobic ligand in its interior. Isoform 2 is expressed in colorectal adenocarcinomas and their adjacent normal mucosa (at protein level)... | |||
TMPJ-00207 |
AKR1C2 Protein, Human, Recombinant
3-Alpha-HSD3,Chlordecone Reductase Homolog HAKRD,2-Diol Dehy... |
Human | E. coli |
Aldo-Keto Reductase Family 1 Member C2 (AKR1C2) plays a role in concert with the 5-α/5-β-Steroid Reductases to convert Steroid hormones into the 3-α/5-α and 3-α/5-β-Tetrahydrosteroids. AKR1C2 catalyzes the inactivation of the most potent androgen 5-α-Dihydrotestosterone (5-α-DHT) to 5-α-Androstane-3-α, 17-β-diol (3-α-diol). | |||
TMPY-02907 |
FGF-19 Protein, Human, Recombinant
fibroblast growth factor 19,FGF19 |
Human | E. coli |
FGF19, also known as FGF-19, is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. FGF19 interacts with FGFR1, FGFR2, FGFR3 and FGFR4. Affinity between fibroblast growth factors (FGFs) and their receptors is increased by KL, KLB and heparan sulfate glycosaminoglyca... | |||
TMPH-02652 |
FGF-15 Protein, Mouse, Recombinant (His & SUMO)
Fibroblast growth factor 15,Fgf15 |
Mouse | E. coli |
Involved in the suppression of bile acid biosynthesis through down-regulation of CYP7A1 expression. | |||
TMPY-02249 |
FABP6 Protein, Human, Recombinant
I-BABP,I-BAP,ILLBP,I-15P,ILBP3,I-BALB,ILBP,fatty acid |
Human | E. coli |
Gastrotropin, also known as Fatty acid-binding protein 6, Ileal lipid-binding protein, ILBP, Intestinal 15 kDa protein, Intestinal bile acid-binding protein, I-BABP and FABP6, is a cytoplasm protein which belongs to thecalycin superfamily and Fatty-acid binding protein (FABP) family. Isoform2 of FABP6 is expressed in colorectal adenocarcinomas and their adjacent normal mucosa (at protein level). Isoform1of FABP6 is expressed in the jejunum, ileum, cecum and ascending colon intestine. Isof... | |||
TMPH-02681 |
GPX7 Protein, Mouse, Recombinant (His & Myc)
Glutathione peroxidase 7,Gpx7 |
Mouse | E. coli |
It protects esophageal epithelia from hydrogen peroxide-induced oxidative stress. It suppresses acidic bile acid-induced reactive oxigen species (ROS) and protects against oxidative DNA damage and double-strand breaks. GPX7 Protein, Mouse, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 26.7 kDa and the accession number is Q99LJ6. | |||
TMPH-00721 |
YgiS Protein, E. coli, Recombinant (His & SUMO)
Probable deoxycholate-binding periplasmic protein YgiS,ygiS |
E. coli | E. coli |
Probably part of a deoxycholate transport system. Its expression in the presence of deoxycholate in a ygiS deletion mutant increases intracellular deoxycholate levels and decreases cell growth; higher expression in the presence of deoxycholate inhibits cell growth completely. Bile acid detergents such as deoxycholate are important for host defense against bacterial growth in the gall bladder and duodenum. | |||
TMPY-00481 |
AKR1C4 Protein, Human, Recombinant (His)
aldo-keto reductase family 1, member C4,3-alpha-HSD,DD4,CHDR... |
Human | E. coli |
Aldo-keto reductases comprise of AKR1C1-AKR1C4, four enzymes that catalyze NADPH dependent reductions and have been implicated in biosynthesis, intermediary metabolism, and detoxification. there is a strong correlation between the expression levels of these family members and the malignant transformation as well as the resistance to cancer therapy. Type I human hepatic 3alpha-hydroxysteroid dehydrogenase (AKR1C4) plays a significant role in bile acid biosynthesis, steroid hormone metabolism, an... | |||
TMPY-01878 |
L-FABP Protein, Human, Recombinant (His)
fatty acid binding protein 1, liver,FABPL,L-FABP |
Human | E. coli |
Fatty acid-binding protein, liver, also known as Fatty acid-binding protein 1, Liver-type fatty acid-binding protein, FABP1 and FABPL,is a cytoplasm protein which belongs to thecalycin superfamily and Fatty-acid binding protein (FABP) family. Fatty acid binding proteins are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. FABP1 and FABP6 (the ileal fatty acid binding protein) are also able to bind bile acids. It is t... | |||
TMPY-03497 |
AKR1C2 Protein, Human, Recombinant (His)
AKR1C2,HBAB,SRXY8,AKR1C-pseudo,aldo-keto reductase family 1,... |
Human | E. coli |
AKR1C2 is a member of the aldo/keto reductase superfamily, which consists of more than 4 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols using NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme binds bile acid with high affinity, and shows minimal 3-alpha-hydroxysteroid dehydrogenase activity. AKR1C2 gene shares high sequence identity with three other gene ... | |||
TMPJ-00715 |
FGF-19 Protein, Human, Recombinant (His)
FGF-19,Fibroblast growth factor 19,FGF19 |
Human | E. coli |
Fibroblast growth factor 19 (FGF19) is a secreted protein which belongs to the FGFs family. FGF19 is expressed in fetal brain, cartilage, retina, and adult gall bladder. FGFs modulate cellular activity via at least 5 distinct subfamilies of high-affinity FGF receptors (FGFRs): FGFR-1, -2, -3, and -4, all with intrinsic tyrosine kinase activity. FGFRs can be important for regulation of glucose and lipid homeostasis. FGF19 has important roles as a hormone produced in the ileum in response to bile ... | |||
TMPY-04813 |
ACAT2 Protein, Rat, Recombinant (His)
acetyl-CoA acetyltransferase 2 |
Rat | E. coli |
Acyl-coenzyme A: cholesterol acyltransferase (ACAT) is an intracellular enzyme that produces cholesteryl esters in various tissues. In mammals, two ACAT genes (ACAT1 and ACAT2) have been identified. Together, these two enzymes are involved in storing cholesteryl esters as lipid droplets, in macrophage foam-cell formation, in absorbing dietary cholesterol, and in supplying cholesteryl esters as part of the core lipid for lipoprotein synthesis and assembly. The key difference in tissue distributio... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMIH-0257 |
Glycoursodeoxycholic Acid-d4
|
||
Glycoursodeoxycholic Acid-d4 是 Glycoursodeoxycholic Acid 的氘代化合物。Glycoursodeoxycholic Acid 的 CAS 号为 64480-66-6。Glycoursodeoxycholic acid 是一种酰基甘氨酸和胆汁酸-甘氨酸缀合物,是熊去氧胆酸的代谢物。 | |||
TMID-0058 |
Glycocholic acid-d4
|
||
Glycocholic acid-d4 是 Glycocholic acid 的氘代化合物。Glycocholic acid 的 CAS 号为 475-31-0。Glycocholic acid 是一种胆汁酸,具有抗肿瘤活性,能够靶向作用于耐药泵和非耐药泵通路。 | |||
TMIJ-0332 |
Taurolithocholic Acid-d5 Sodium Salt (Major)
|
||
Taurolithocholic Acid-d5 Sodium Salt (Major) 是 Taurolithocholic Acid Sodium Salt 的氘代化合物。Taurolithocholic Acid Sodium Salt 的 CAS 号为 6042-32-6。Taurolithocholic acid sodium salt 是抑胆剂和Ca2+激动剂,可抑制放射性配体与毒蕈碱 M1 结合。 | |||
TMIH-0552 |
Tauroursodeoxycholic Acid-d4 Sodium Salt
|
||
Tauroursodeoxycholic Acid-d4 Sodium Salt 是 Tauroursodeoxycholic Acid Sodium Salt 的氘代化合物。Tauroursodeoxycholic Acid Sodium Salt 的 CAS 号为 14605-22-2。Tauroursodeoxycholate,又称 ursodoxicoltaurine,是一种高度亲水性的三级胆汁酸,在人体内以低浓度产生。Tauroursodeoxycholate 是 ursodeoxycholic acid 更亲水的形式,而 ursodeoxycholic acid 是人类体内自然产生的更丰富的胆汁酸。Tauroursodeoxycholate 正在研究用于几种疾病,如原发性胆汁性肝硬化(PBC)、胰岛素抵抗、淀粉样变性、囊性纤维化、胆汁淤滞和肌萎缩性侧索硬化症。 | |||
TMIJ-0197 |
Tauroursodeoxycholic-2,2,3,4,4-d5 Acid
|
||
Tauroursodeoxycholic-2,2,3,4,4-d5 Acid 是 Tauroursodeoxycholic Acid 的氘代化合物。Tauroursodeoxycholic Acid 的 CAS 号为 14605-22-2。Tauroursodeoxycholate,又称 ursodoxicoltaurine,是一种高度亲水性的三级胆汁酸,在人体内以低浓度产生。Tauroursodeoxycholate 是 ursodeoxycholic acid 更亲水的形式,而 ursodeoxycholic acid 是人类体内自然产生的更丰富的胆汁酸。Tauroursodeoxycholate 正在研究用于几种疾病,如原发性胆汁性肝硬化(PBC)、胰岛素抵抗、淀粉样变性、囊性纤维化、胆汁淤滞和肌萎缩性侧索硬化症。 | |||
TMIJ-0199 |
Tauroursodeoxycholic-d4 Acid
Tauroursodiol-d4 |
||
Tauroursodeoxycholic-d4 Acid 是 Tauroursodeoxycholic Acid 的氘代化合物。Tauroursodeoxycholic Acid 的 CAS 号为 14605-22-2。Tauroursodeoxycholate,又称 ursodoxicoltaurine,是一种高度亲水性的三级胆汁酸,在人体内以低浓度产生。Tauroursodeoxycholate 是 ursodeoxycholic acid 更亲水的形式,而 ursodeoxycholic acid 是人类体内自然产生的更丰富的胆汁酸。Tauroursodeoxycholate 正在研究用于几种疾病,如原发性胆汁性肝硬化(PBC)、胰岛素抵抗、淀粉样变性、囊性纤维化、胆汁淤滞和肌萎缩性侧索硬化症。 | |||
TMIJ-0304 |
Lithocholic Acid-d4
|
||
Lithocholic Acid-d4 是 Lithocholic Acid 的氘代化合物。Lithocholic Acid 的 CAS 号为 434-13-9。Lithocholic acid是由鹅去氧胆酸盐通过细菌作用形成的胆汁酸,通常与甘氨酸或牛磺酸结合,被用作利胆剂。 它作为清洁剂溶解脂肪以供吸收,并且本身被吸收。 | |||
TMID-0294 |
Taurodeoxycholic Acid-d4 Sodium Salt
|
||
Taurodeoxycholic Acid-d4 Sodium Salt 是 Taurodeoxycholic Acid Sodium Salt 的氘代化合物。Taurodeoxycholic Acid Sodium Salt 的 CAS 号为 1180-95-6。Taurodeoxycholate sodium salt 是胆盐相关的阴离子洗涤剂,用于分离膜蛋白,包括线粒体内膜蛋白。它还可以抑制各种炎症反应。 | |||
TMID-0052 |
Taurocholic Acid-d4 Sodium
|
||
Taurocholic Acid-d4 Sodium 是 Taurocholic Acid Sodium 的氘代化合物。Taurocholic Acid Sodium 的 CAS 号为 145-42-6。Sodium taurocholate hydrate 具有显著的生物学效应,例如通过上调 VEGF-A 的表达抑制肝动脉结扎所致的胆道损伤。对免疫系统具有一定的调节作用。 | |||
TMIJ-0198 |
Taurochenodeoxycholic Acid-d5 Sodium Salt
|
||
Taurochenodeoxycholic Acid-d5 Sodium Salt 是 Taurochenodeoxycholic Acid Sodium Salt 的氘代化合物。Taurochenodeoxycholic Acid Sodium Salt 的 CAS 号为 6009-98-9。Taurochenodeoxycholic acid sodium 是动物胆汁酸的主要生物活性物质之一。它可诱导细胞凋亡,具有抗炎和免疫调节作用。 | |||
TMIH-0209 |
Elobixibat-d5
|
||
Elobixibat-d5 是 Elobixibat 的氘代化合物。Elobixibat 的 CAS 号为 439087-18-0。Elobixibat 是回肠胆汁酸转运蛋白的抑制剂(小鼠、人和犬 IBAT 的 IC50:0.13 nM、0.53 nM 和 5.8 nM)。 Elobixibat 可用于慢性特发性便秘的研究。 |